Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 204 institutions that hold shares in the stock, with a total of 66.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.71 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
591,689
shares
|
$15.1 Million
0.88% of portfolio
|
Q3 2025
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
553,873
shares
|
$14.2 Million
0.0% of portfolio
|
Q3 2025
Added 0.14%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Nov 12, 2025 Q3 2025 |
528,597
shares
|
$13.5 Million
0.19% of portfolio
|
Q3 2025
Added 36.28%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
497,270
shares
|
$12.7 Million
8.63% of portfolio
|
Q4 2023
Added 60.27%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
416,447
shares
|
$10.6 Million
0.0% of portfolio
|
Q3 2025
Reduced 50.5%
|
|
|
Tsp Capital Management Group, LLC
|
Oct 22, 2025 Q3 2025 |
375,927
shares
|
$9.6 Million
2.8% of portfolio
|
Q3 2025
Added 1.21%
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
348,922
shares
|
$8.91 Million
1.86% of portfolio
|
Q3 2025
Added 75.83%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
338,811
shares
|
$8.66 Million
0.0% of portfolio
|
Q3 2025
Added 22.68%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
327,008
shares
|
$8.36 Million
0.93% of portfolio
|
Q3 2025
Reduced 4.67%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
319,332
shares
|
$8.16 Million
0.0% of portfolio
|
Q3 2025
Reduced 15.69%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
311,919
shares
|
$7.97 Million
0.0% of portfolio
|
Q3 2025
Reduced 52.85%
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Nov 14, 2025 Q3 2025 |
303,600
shares
|
$7.76 Million
1.74% of portfolio
|
Q3 2025
Reduced 3.97%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
300,000
shares
|
$7.67 Million
0.9% of portfolio
|
Q3 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
288,378
shares
|
$7.37 Million
0.0% of portfolio
|
Q4 2024
Reduced 20.7%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
257,332
shares
|
$6.57 Million
0.0% of portfolio
|
Q3 2025
Reduced 60.14%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
257,083
shares
|
$6.57 Million
0.0% of portfolio
|
Q3 2025
Added 78.67%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
249,195
shares
|
$6.37 Million
0.0% of portfolio
|
Q3 2025
Reduced 6.16%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
244,825
shares
|
$6.26 Million
0.0% of portfolio
|
Q3 2025
Reduced 6.81%
|
|
|
Ci Private Wealth, LLC
Miami, FL |
Nov 14, 2025 Q3 2025 |
239,606
shares
|
$6.12 Million
0.01% of portfolio
|
Q3 2025
Added 18.78%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2025 Q3 2025 |
207,764
shares
|
$5.31 Million
1.41% of portfolio
|
Q3 2025
Reduced 50.48%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
199,291
shares
|
$5.09 Million
0.03% of portfolio
|
Q3 2025
Reduced 86.72%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
194,588
shares
|
$4.97 Million
0.01% of portfolio
|
Q3 2025
Added 7.28%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
184,775
shares
|
$4.72 Million
0.0% of portfolio
|
Q3 2025
Reduced 23.44%
|
|
|
Mirador Capital Partners LP
|
Oct 06, 2025 Q3 2025 |
165,921
shares
|
$4.24 Million
0.63% of portfolio
|
Q3 2025
Added 4.54%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 12, 2025 Q3 2025 |
155,000
shares
|
$3.96 Million
4.01% of portfolio
|
Q3 2025
New holding
|
|